CACarlo Angioni

Carlo Angioni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carlo Angioni has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Yannick Schreiber

    Institute of Clinical Pharmacology, Goethe University Frankfurt, Faculty of Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany

    2 shared publications
  • Alexander Perniss

    Institute of Anatomy and Cell Biology, German Center for Lung Research, Justus Liebig University Giessen, Giessen, Germany

    1 shared publication
  • Amir Rafiq

    Institute of Anatomy and Cell Biology, German Center for Lung Research, Justus Liebig University Giessen, Giessen, Germany

    1 shared publication
  • Anna-Lena Ruppert

    Institute of Anatomy and Cell Biology, Philipps University, Marburg, Germany

    1 shared publication
  • Astrid Stefanie Kahnt

    Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt am Main, Germany

    1 shared publication
  • Bettina Hofmann

    Institute of Pharmaceutical Chemistry Johann Wolfgang Goethe‐Universität Frankfurt Frankfurt Germany

    1 shared publication

Latest Publications

  • Open Access

    Temporary deterioration of health and behavior during pexidartinib-mediated microglia depletion and repopulation in progranulin-deficient mice

    by Marc-Philipp Weyer, Lisa Hahnefeld, Luisa Franck, Yannick Schreiber, Carlo Angioni, Michael K.E. Schaefer, Irmgard Tegeder

    Progranulin (PGRN) is a neurotrophic and anti-inflammatory factor produced mainly by neurons and microglia in the central nervous system. Progranulin haploinsufficiency causes frontotemporal dementia (FTD). In a previous study we showed that transgenic restoration of progranulin in neurons in progranulin knockout mice (NestinGrn KOBG k nock o ut b ack g round) did not prevent the dementia-like phenotype. Here, we assessed if pharmacologic microglia depletion via PLX3397-diet (CSF1R-antagonist) had therapeutic value in these mice. Microglia depletion and spontaneous repopulation was confirmed in immunofluorescence and rtPCR studies. There was no difference in depletion or repopulation efficiency between NesGrn KOBG, PGRN KO and heterozygous (het) PGRN mice, but microglia repopulated faster than in control Grn-flfl mice, and the morphology of primary PGRN deficient microglia during repopulation was closer to homeostatic microglia, and it was accompanied by a remarkable restoration of dendritic spines and synaptic structures. Regardless of these positive effects, NesGrn KOBG and PGRN het mice experienced serious side effects during microglia depletion which peaked around the microglia nadir. Overactivity and excessive grooming escalated and caused serious skin lesions. Bulk transcriptomic and metabolomic studies in the brain taken 8 weeks after the end of PLX-diet clearly revealed differences between genotypes but mostly no lasting impact of PLX-diet, except for a further increase of proinflammatory genes, cathepsins and complement factors in PLX-treated groups. Cell type specific lipidomic studies revealed a time dependent switch not only in microglia but also astrocytes upon PLX3397 treatment. While nadir-microglia were triglyceride-laden, repopulated microglia returned to normal TG levels but were enriched in ether-bound phosphatidylcholines (PC-O) and lysophosphatidylglycerol species which are pro-inflammatory lipids; and astrocytes overtook the TG burden during repopulation. Our data suggest that microglia depletion may cause a deterioration in progranulin-deficiency.

  • Cysteinyl leukotrienes and acetylcholine are biliary tuft cell cotransmitters

    by Maryam Keshavarz, Schayan Faraj Tabrizi, Anna-Lena Ruppert, Uwe Pfeil, Yannick Schreiber, Jochen Klein, Isabell Brandenburger, Günter Lochnit, Sudhanshu Bhushan, Alexander Perniss, et al.

    The gallbladder stores bile between meals and empties into the duodenum upon demand and is thereby exposed to the intestinal microbiome. This exposure raises the need for antimicrobial factors, among them, mucins produced by cholangiocytes, the dominant epithelial cell type in the gallbladder. The role of the much less frequent biliary tuft cells is still unknown. We here show that propionate, a major metabolite of intestinal bacteria, activates tuft cells via the short-chain free fatty acid receptor 2 and downstream signaling involving the cation channel transient receptor potential cation channel subfamily M member 5. This results in corelease of acetylcholine and cysteinyl leukotrienes from tuft cells and evokes synergistic paracrine effects upon the epithelium and the gallbladder smooth muscle, respectively. Acetylcholine triggers mucin release from cholangiocytes, an epithelial defense mechanism, through the muscarinic acetylcholine receptor M3. Cysteinyl leukotrienes cause gallbladder contraction through their cognate receptor CysLTR1, prompting emptying and closing. Our results establish gallbladder tuft cells as sensors of the microbial metabolite propionate, initiating dichotomous innate defense mechanisms through simultaneous release of acetylcholine and cysteinyl leukotrienes.


  • Cysteinyl leukotriene-receptor-1 antagonists interfere with PGE2 synthesis by inhibiting mPGES-1 activity

    by Astrid Stefanie Kahnt, Florian Rörsch, Olaf Diehl, Bettina Hofmann, Christoph Lehmann, Svenja Dorothea Steinbrink, Carlo Angioni, Gerd Geisslinger, Sabine Grösch, Dieter Steinhilber, et al.